Skip to main content

CLGN · CollPlant Biotechnologies Ltd · Holdings

Track CLGN — free
$3.81 -0.07 (-1.80%)
Market Cap
$7.34M
Shares
1.89M
Volume · Oct 20 20.36K Avg daily vol (32 sessions) 80.78K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Institutional holdings are being reconciled with SEC filings. Holder totals and changes may be incomplete until reconciliation finishes.
The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 14
Total Value: $594,395
Total Shares: 1,005,551

Institutional Ownership Trend

22 quarters

Holder Concentration

Across 15 13F filers
Top Holder
43.9%
Sep 2023 → Jun 2026 · range 29.2% – 44.1%
of institutional value
Top 5
93.7%
Sep 2023 → Jun 2026 · range 87.9% – 97.9%
of institutional value
Top 10
100.0%
Sep 2023 → Jun 2026 · range 98.3% – 100.0%
of institutional value
HHI
3,331
Sep 2023 → Jun 2026 · range 1,987 – 3,669
Highly concentrated

Who Holds CLGN

Last 8 quarters through Sep 30, 2026 (filing window open)

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Jun 30, 2026, the newest closed quarter: 14 filers, like-for-like change +9.3%; actively managed books +9.3%.

Holder type Share Filers Change
Registered adviser 89.1% 7 +14.0%
Bank 0.1% 1 +160.0%
Non-US 0.0% 1 0.0%
Holding company 0.0% 1 0.0%
Broker-dealer 0.0% 0 -100.0%
Unknown 10.8% 4 -18.1%

The Sep 30, 2026 filing window is still open, so its bar carries the Jun 30, 2026 positions of filers that have not filed yet.

How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Conviction and Crowding

15 13F filers, quarter ended Jun 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
0
0.000% of filers hold it in their top 10
Mar 31, 2026: 0
Holders above 5%
0
median weight 0.000%
Mar 31, 2026: 0
Crowding
—
a foreign private issuer reports ordinary shares, a different unit from the listed shares
Private-fund advisers
—
of shares outstanding
Institutional ownership
—
a foreign private issuer reports ordinary shares, a different unit from the listed shares
Top 10 holders
99.9%
of 13F shares, Herfindahl 0.331
Active holders
+9.3%
like-for-like share change of active filers
5% stakes on record
0
0 13D, 0 13G
How long holders have held it value-weighted 15.3 quarters
Under 1 year 5.47% 1 to 3 years 7.94% 3 years or more 86.6% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $0 (0 buying, 0 selling).

Estimated Holder Cost Basis

Quarter ended Jun 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$6.44
estimated per share
Mar 31, 2026: $7.17
Quarter-end price
$0.35
implied by 13F values
Estimated gain or loss
-94.6%
price against the estimated cost
Estimated at a loss
100.0%
of costed 13F value

Estimated cost covers 99.7% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shareholder Targets

13F filers that own its peers but not CLGN, quarter ended Jun 30, 2026

CLGN has no holder-overlap peers, so these filers hold the largest Healthcare stocks: LLY, JNJ, ABBV, UNH, MRK, TMO, AMGN, AZN, GILD, ABT, ISRG, VRTX, CVS, DHR, SYK, BMY, PFE, MDT, MCK, ELV. 6,275 filers in all.

# Filer In peers
1 BlackRock, Inc. Holding company, Index-like $399,992,110,610 20 held
2 VANGUARD CAPITAL MANAGEMENT LLC Registered adviser, Index-like $308,266,564,827 20 held
3 STATE STREET CORP Bank, Index-like $222,713,276,889 20 held
4 VANGUARD PORTFOLIO MANAGEMENT LLC Registered adviser, Diversified active $116,012,260,024 20 held
5 GEODE CAPITAL MANAGEMENT, LLC Registered adviser, Index-like $112,944,926,328 19 held
6 LILLY ENDOWMENT INC Unknown, Unknown $108,400,867,760 1 held
7 FMR LLC Holding company, Diversified active $102,008,860,554 20 held
8 JPMORGAN CHASE & CO Bank, Diversified active $92,751,126,760 20 held
9 Capital World Investors Adviser, Diversified active $89,827,396,720 14 held
10 NORGES BANK Non-US, Index-like $70,478,623,091 20 held
Showing 14 of 14
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1631487 CUSIP M2R51X124 13F (30d) 1 filings 1 filers Visit website Investor relations